Search results for “Pyrazine” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 14,122 patents, we discovered top 477 key players by total patent application. F. Hoffmann-La Roche Ltd., Janssen Pharmaceutica NV, Novartis AG are dominant in this area. They take 11.67% of the total patent filing.
Switzerland
Patent: 773
Antwerpen, Belgium
Patent: 494
Basel-Stadt, Switzerland
Patent: 381
New York, United States
Patent: 323
Jiangsu Sheng, China
Patent: 242
Hessen, Germany
Patent: 237
New Jersey, United States
Patent: 188
Massachusetts, United States
Patent: 188
Indiana, United States
Patent: 180
France
Patent: 178
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 106 patents, we discovered top 23 start-ups by total patent application. KaNDy Therapeutics Ltd., Navire Pharma, Inc., Step Pharma SAS are active in this area.
STARTUP
Herefordshire, United Kingdom
Patent: 27
STARTUP
California, United States
Patent: 14
STARTUP
France
Patent: 13
STARTUP
Guangdong Sheng, China
Patent: 9
STARTUP
South Korea
Patent: 7
STARTUP
Basel-Stadt, Switzerland
Patent: 5
Illinois, United States
Patent: 4
STARTUP
Massachusetts, United States
Patent: 4
STARTUP
New York, United States
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 3,350 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Incyte Corp., Novartis AG take 8.63% of patent filing during this period.
Switzerland
Patent: 140
Delaware, United States
Patent: 86
Basel-Stadt, Switzerland
Patent: 63
Kyoto-fu, Japan
Patent: 63
Nordrhein-Westfalen, Germany
Patent: 61
Rheinland-Pfalz, Germany
Patent: 61
Massachusetts, United States
Patent: 48
Nordrhein-Westfalen, Germany
Patent: 46
Antwerpen, Belgium
Patent: 42
California, United States
Patent: 37
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 3,350 patents in last 5 years, we discover 288 new entrants. AiCuris GmbH & Co. KG, Nuvation Bio, Inc., Dizal Pharmaceutical Co., Ltd are the most active new entrants in this area.
Nordrhein-Westfalen, Germany
Patent: 61
New York, United States
Patent: 26
Jiangsu Sheng, China
Patent: 24
ZURICH, Switzerland
Patent: 23
Fujian Sheng, China
Patent: 20
undefined undefined
Patent: 20
Massachusetts, United States
Patent: 19
Jiangsu Sheng, China
Patent: 18
Jiangsu Sheng, China
Patent: 17
North Carolina, United States
Patent: 16
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,307 patents, we discovered top 283 universities and scientific research institutions by total patent application. Institute Of Cancer Research, Capital University of Medical Sciences, Swiss Federal Institute of Technology Zurich are dominant in this area. They take 12.85% of the total patent filing.
United Kingdom
Patent: 37
Beijing Shi, China
Patent: 25
ZURICH, Switzerland
Patent: 23
Jiangsu Sheng, China
Patent: 21
Delhi, India
Patent: 19
Guangxi Zhuangzu Zizhiqu, China
Patent: 19
Zhejiang Sheng, China
Patent: 18
Zhejiang Sheng, China
Patent: 17
Jiangsu Sheng, China
Patent: 17
Shandong Sheng, China
Patent: 15
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: